Rhelion Life Sciences Corp (RHEL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 80 | 85 | 98 | 95 | 110 |
| Income taxes - deferred | -207 | -29 | -32 | -27 | -70 |
| Accounts receivable | 337 | -337 | -22 | -79 | 43 |
| Other Working Capital | 369 | -88 | 22 | 185 | 408 |
| Other Operating Activity | -1,039 | -433 | -822 | -578 | -1,040 |
| Operating Cash Flow | $-461 | $-801 | $-757 | $-403 | $-549 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,088 | -3 | -2 | -132 | -39 |
| Purchase Of Investment | N/A | -313 | -463 | -210 | N/A |
| Other Investing Activity | 986 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-102 | $-317 | $-465 | $-342 | $-39 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -177 | 177 | 0 | -648 | 23 |
| Debt Repayment | -25 | -25 | -34 | -33 | 50 |
| Financing Cash Flow | $-202 | $151 | $-34 | $-681 | $73 |
| Exchange Rate Effect | -1 | -23 | 28 | 43 | 63 |
| Beginning Cash Position | 9,238 | 10,226 | 11,454 | 12,838 | 13,291 |
| End Cash Position | 8,471 | 9,238 | 10,226 | 11,454 | 12,838 |
| Net Cash Flow | $-766 | $-966 | $-1,256 | $-1,427 | $-515 |
| Free Cash Flow | |||||
| Operating Cash Flow | -461 | -801 | -757 | -403 | -549 |
| Capital Expenditure | -1,088 | -3 | -2 | -132 | -39 |
| Free Cash Flow | -1,549 | -804 | -759 | -535 | -588 |